What role can OCT angiography play in tracking the development of central serous retinopathy (CSR)? Yasha Modi, MD, and Kat Talcott, MD, review the use of OCT angiography in a real-world CSR case, discuss the value of selecting OCT angiography over fluorescein angiography for patients with neovascularization, and parse which populations are not a good fit for OCT angiography.
This episode is supported by Zeiss Professional Education.
Information
- Show
- FrequencyEvery two weeks
- Published9 January 2025 at 05:01 UTC
- Length18 min
- RatingClean